Skip to main content

Number and Tumor Size Are Not Sufficient Criteria to Select Patients for Liver Transplantation for Hepatocellular Carcinoma

Annals of Surgical Oncology volume 19, pages 2020–2026 (2012)Cite this article

Abstract

Background

Hepatocellular carcinoma (HCC) is an indication for liver resection or transplantation (LT). In most centers, patients whose HCC meets the Milan criteria are considered for LT. The first objective of this study was to analyze whether there is a correlation between the pathologic characteristics of the tumor, survival and recurrence rate. Second, we focused our attention on vascular invasion (VI).

Methods

From January 1997 to December 2007, a total of 196 patients who had a preoperative diagnosis of HCC were included. The selection criteria for LT satisfied both the Milan and the San Francisco criteria (UCSF). Demographic, clinical, and pathologic information were recorded.

Results

HCC was confirmed in 168 patients (85.7%). The median follow-up was 74 months. The pathologic findings showed that 106 patients (54.1%) satisfied the Milan criteria, 134 (68.4%) the UCSF criteria of whom 28 (14.3%) were beyond the Milan criteria but within the UCSF criteria, and 34 (17.3%) beyond the UCSF criteria. VI was detected in 41 patients (24%). The 1-, 3-, and 5-year overall survival rates were 90%, 85%, and 77%, respectively, according to the Milan criteria and 90%, 83%, and 76%, respectively, according to the UCSF criteria (P = NS). In univariate and multivariate analyses, tumor size and VI were significant prognostic factors affecting survival (P < 0.001). Two factors were significantly associated with VI: alfa-fetoprotein level of >400 ng/ml and tumor grade G3.

Conclusions

Tumor size and VI were the only significant prognostic factors affecting survival of HCC patients. Primary liver resection could be a potential selection treatment before LT.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3

References

  1. Belghiti J, Panis Y, Farges O, Benhamou JP, Fekete F. Intrahepatic recurrence after resection of hepaocellular carcinoma complicating cirrhosis. Ann Surg. 1991;214:114–7.

    PubMed  Article  CAS  Google Scholar 

  2. Mazzaferro V, Regalia E, Doci R, et al. Liver Transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis. N Engl J Med. 1996;334:693–9.

    PubMed  Article  CAS  Google Scholar 

  3. Schwartz ME, D’Amico F, Vitale A, Emre S, Cillo U. Liver transplantation for hepatocellular carcinoma: are the Milan criteria still valid? Eur J Surg Oncol. 2008;34:256–62.

    PubMed  Article  CAS  Google Scholar 

  4. Duffy JP, Vardanian A, Benjamin E, et al. Liver transplantation criteria for hepatocellular carcinoma should be explained: a 22-year experience with 467 patients at UCLA. Ann Surg. 2007;246:502–9.

    PubMed  Article  Google Scholar 

  5. Piardi T, Audet M, Odeh M, et al. Liver transplantation exceeding UCSF criteria: case repost of a late recurrence treated by surgery and review of the literature. Eur Surg Res. 2010;44:52–5.

    PubMed  Article  CAS  Google Scholar 

  6. Pawlik TM, Delman KA, Vauthey JN, et al. Tumor size predicts vascular invasion and histologic grade: implication for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl. 2005;11:1086–92.

    PubMed  Article  Google Scholar 

  7. Mazzaferro V, Llovet JM, Miceli R, et al. Predicting survival after live transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol. 2009;10:35–42.

    PubMed  Article  Google Scholar 

  8. Bruix J, Sherman M, Llovet M, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. J Hepatol. 2001;35:421–30.

    PubMed  Article  CAS  Google Scholar 

  9. Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology. 2001;33:1394–403.

    PubMed  Article  CAS  Google Scholar 

  10. Audet M, Piardi T, Panaro F, et al. Four hundred and twenty-three consecutive adults piggy-back liver transplantations with the three suprahepatic veins: was the portal systemic shun required? J Gastroenterol Hepatol. 2010;25:591–6.

    PubMed  Article  Google Scholar 

  11. Edmonson HA. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer. 1954;7:462–503.

    Article  Google Scholar 

  12. Ikai I, Yamamoto Y, Yamamoto N, et al. Results of hepatic resection for hepatocellular carcinoma invading major portal and/or hepatic veins. Surg Oncol Clin N Am. 2003;12:65–75.

    PubMed  Article  Google Scholar 

  13. Hermanek P, Hendson D, Hutter R. TNM supplement 1993: a commentary on uniform use. Berlin: Springer-Verlag, 1993.

    Book  Google Scholar 

  14. AJCC Cancer staging handbook. TNM liver classification. In: Greene FL, Page DL, Fleming ID, et al., editors. American Joint Committee on Cancer (AJCC) cancer staging manual. 6th ed. New York: Springer-Verlag, 2005:1208–36.

    Google Scholar 

  15. Anderson TW. On the distribution of the two-sample Cramer–von Mises criterion. Ann Math Stat. 1962;33:1148–59.

    Article  Google Scholar 

  16. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma:resection versus transplantation. Hepatology. 1999;30:1434–40.

    PubMed  Article  CAS  Google Scholar 

  17. Neuberger J. Liver-cell cancer and transplantation. Lancet Oncol. 2009;10:5–7.

    PubMed  Article  Google Scholar 

  18. Washburn K, Edwards E, Harper A, et al. Hepatocellular carcinoma patients are advantaged in the current liver transplant allocation system. Am J Transplant. 2010;10:1643–8.

    PubMed  Article  CAS  Google Scholar 

  19. Yao FY, Hirose R, La Berge JM, et al. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl. 2005;11:1505–14.

    PubMed  Article  Google Scholar 

  20. Dubay D, Sandroussi C, Sandhu L, et al. Liver transplantation for advanced hepatocellular carcinoma using poor tumor differentiation on biopsy as an exclusion criterion. Ann Surg. 2011;253:166–72.

    PubMed  Article  Google Scholar 

  21. Cillo U, Vitale A, Bassanello M, et al. Liver transplantation for the treatment of moderately or well-differentiated heptocellurlar carcinoma. Ann Surg. 2004;239:150–9.

    PubMed  Article  Google Scholar 

  22. Shah SA, Tan JC, McGilvray ID, et al. Accuracy of staging as a predictor for recurrence after liver transplantation for hepatocellular carcinoma. Transplantation. 2006;81:1633–9.

    PubMed  Article  Google Scholar 

  23. D’Amico F, Schwartz M, Vitale A, et al. Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria. Liver Transpl. 2009;15:1278–87.

    PubMed  Article  Google Scholar 

  24. Lai Q, Merli M, Corradini S, et al. Predictive factors of recurrence of hepatocellular carcinoma after liver transplantation: a multivariate analysis. Transpl Proc. 2009;41:1306–9.

    Article  CAS  Google Scholar 

  25. Jonas S, Bechstein WO, Steinmuller T, et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology. 2001;33:1080–6.

    PubMed  Article  CAS  Google Scholar 

  26. Schwartz M. Liver transplantation: the preferred treatment for early hepatocellular carcinoma in the setting of cirrhosis? Ann Surg Oncol. 2005;14:548–52.

    Article  Google Scholar 

  27. Pomfret EA, Washburn K, Wald C, et al. Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States. Liver Transpl. 2010;16:262–78.

    PubMed  Article  Google Scholar 

  28. Salizzoni M, Romagnoli R, Lupo F, et al. Microscopic vascular invasion detected by anti-CD34 immunohistochemistry as a predictor of recurrence of hepatocellular carcinoma after liver transplantation. Transplantation. 2003;76:844–8.

    PubMed  Article  Google Scholar 

  29. Sumie S, Kuromatsu R, Okuda K, et al. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol. 2008;15:1375–82.

    PubMed  Article  Google Scholar 

  30. Lohe F, Angele MK, Rentsch M, et al. Multifocal manifestation does not affect vascular invasion of hepatocellular carcinoma: implications for patient selection in liver transplantation. Clin Transplant. 2007;21:696–71.

    Google Scholar 

  31. Parfitt JR, Marotta P, AlGhamdi M, et al. Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence. Liver Transpl. 2007;13:543–51.

    PubMed  Article  Google Scholar 

  32. Shetty K, Timmins K, Brensinger C, et al. Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome. Liver Transpl. 2004;10:911–8.

    PubMed  Article  Google Scholar 

  33. Vibert E, Azoulay D, Hoti E, et al. Progression of alphafetoprotein before liver transplantation for hepatocellular carcinoma in cirrhotic patients: a critical factor. Am J Transplant. 2010;10:129–37.

    PubMed  Article  CAS  Google Scholar 

  34. Klintmalm GB. Liver Transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome. Ann Surg. 1998;228:479–90.

    PubMed  Article  CAS  Google Scholar 

  35. Chen JWC, Kow L, Verran DJ, et al. Poorer survival in patients whose explanted hepatocellular carcinoma (HCC) exceeds Milan or UCSF criteria. An analysis of liver transplantation in HCC in Australia and New Zealand. HPB (Oxford). 2009;11:81–9.

    Article  CAS  Google Scholar 

  36. Pawlik T, Glaintzner AL, Anders RA, Assumpcao L, Maley W, Choty MA. Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy. Ann Surg. 2007;245:435–42.

    PubMed  Article  Google Scholar 

  37. Belghiti J. Resection and liver transplantation for HCC. Gastroenterology. 2009;44(Suppl. 19):132–5.

    Google Scholar 

  38. Azagra JS, Goergen M, Gilbart E, et al. Laparoscopic anatomical (hepatic) left lateral segmentectomy—technical aspects. Surg Endosc. 1996;10:758–61.

    PubMed  CAS  Google Scholar 

  39. Huscher CG, Lirici MM, Chiodini S. Laparoscopic liver resections. Semin Laparosc Surg. 1998;5:204–10.

    PubMed  CAS  Google Scholar 

  40. Buell JF, Cherqui D, Geller DA. The international position on laparoscopic liver surgery. Ann Surg. 2009;250:825–30.

    PubMed  Article  Google Scholar 

  41. Dagher I, Belli G, Fantini C, et al. Laparoscopic hepatectomy for hepatocellular carcinoma: a European experience. J Am Coll Surg. 2010;211:16–23.

    PubMed  Article  Google Scholar 

  42. Belghiti J, Durand F. Criteria for liver transplantation for hepatocellular carcinoma: what is an acceptable outcome. Liver Int. 2011;31(Suppl. 1):161–3.

    PubMed  Article  Google Scholar 

  43. Durand F, Belghiti J, Paradis V. Liver transplantation for hepatocellular carcinoma: role of biospy. Liver Transpl. 2007;13:S17–23.

    PubMed  Article  Google Scholar 

Download references

Author information

Affiliations

  1. Pôle de Pathologie Digestive, Hépatique et de Transplantation, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, Université de Strasbourg, Strasbourg, France

    T. Piardi MD, F. Gheza MD, B. Ellero MD, M. L. Woehl-Jaegle MD, D. Ntourakis MD, M. Cantu MD, E. Marzano MD, M. Audet MD, P. Wolf MD, PhD & Patrick Pessaux MD, PhD

Authors
  1. T. Piardi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Gheza MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. Ellero MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. L. Woehl-Jaegle MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D. Ntourakis MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Cantu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. E. Marzano MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M. Audet MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. P. Wolf MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Patrick Pessaux MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Patrick Pessaux MD, PhD.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Piardi, T., Gheza, F., Ellero, B. et al. Number and Tumor Size Are Not Sufficient Criteria to Select Patients for Liver Transplantation for Hepatocellular Carcinoma. Ann Surg Oncol 19, 2020–2026 (2012). https://doi.org/10.1245/s10434-011-2170-9

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-011-2170-9

Keywords

  • Overall Survival
  • Tumor Grade
  • Vascular Invasion
  • Significant Prognostic Factor
  • Milan Criterion